Literature DB >> 2590261

Pharmacological characterisation of the smooth muscle antispasmodic agent tiropramide.

I Setnikar1, R Cereda, M A Pacini, L Revel, F Makovec.   

Abstract

(+/-) Tiropramide hydrochloride, its D and L optical isomers and some of its metabolites were characterized in a number of in vitro pharmacological tests. Tiropramide showed broad spectrum antispasmodic activities on the isolated stomach of guinea pig electrically stimulated; on the longitudinal muscles of the ileum of guinea pig stimulated by electrical impulses, BaCl2, acetylcholine, histamine, serotonin, substance P and cholecystokinin octapeptide (CCK-8); on the spontaneous contractions and on the electrical inhibition of the jejunum of rabbit; on the spontaneous contractions and on the contractions provoked by BaCl2 and acetylcholine of the ascending colon of the rat; on the contractions provoked by BaCl2, acetylcholine, histamine and cerulein of the circular muscles of the gall bladder of the guinea pig; on the spontaneous contractions of the pyel-ureter preparation of the guinea pig; on the contractions of the uterus of the rat provoked by oxitocin, serotonin, acetylcholine, PGF2; on the spontaneous contraction of the portal vein of the rat; on the constriction of the tail artery of the rat provoked by electrical stimulation, epinephrine and ergotamine; on the contractions of the aortic strip of the rabbit stimulated by norepinephrine; on the contractions of the strip of bovine coronary artery depolarized by HCl. In general tiropramide had antispasmodic effect at 5-60 mumol/l concentration. It was more potent than papaverine on contractions provoked by electrical or chemical stimuli, and was less potent or ineffective on spontaneous and "physiological" contractions of the different smooth muscle preparations. Tiropramide had small effects on vascular smooth muscles and showed very small calcium channel blocking activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2590261

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  1 in total

1.  Efficacy and Safety of Tiropramide in the Treatment of Patients With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-blind, Non-inferiority Trial, Compared With Octylonium.

Authors:  Kang Nyeong Lee; Oh Young Lee; Myung-Gyu Choi; Chong Il Sohn; Kyu Chan Huh; Kyung Sik Park; Joong Goo Kwon; Nayoung Kim; Poong-Lyul Rhee; Seung-Jae Myung; Joon Seong Lee; Kwang Jae Lee; Hyojin Park; Yong Chan Lee; Suck Chei Choi; Hye-Kyung Jung; Sam Ryong Jee; Chang Hwan Choi; Gwang Ha Kim; Moo In Park; In Kyung Sung
Journal:  J Neurogastroenterol Motil       Date:  2013-12-30       Impact factor: 4.924

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.